| Loss of p53 drives neuron reprogramming in head and neck cancer M Amit, H Takahashi, MP Dragomir, A Lindemann, FO Gleber-Netto, ... Nature 578 (7795), 449-454, 2020 | 286 | 2020 |
| Targeting the DNA Damage Response in OSCC with TP53 Mutations A Lindemann, H Takahashi, AA Patel, AA Osman, JN Myers Journal of dental research 97 (6), 635-644, 2018 | 131 | 2018 |
| Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity N Tanaka, AA Osman, Y Takahashi, A Lindemann, AA Patel, M Zhao, ... Oral oncology 87, 49-57, 2018 | 113 | 2018 |
| COTI-2, a novel thiosemicarbazone derivative, exhibits antitumor activity in HNSCC through p53-dependent and-independent mechanisms A Lindemann, AA Patel, NL Silver, L Tang, Z Liu, L Wang, N Tanaka, ... Clinical Cancer Research 25 (18), 5650-5662, 2019 | 98 | 2019 |
| Time line of redox events in aging postmitotic cells N Brandes, H Tienson, A Lindemann, V Vitvitsky, D Reichmann, ... Elife 2, e00306, 2013 | 80 | 2013 |
| Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells A Lindemann, K Lüdtke-Buzug, BM Fräderich, K Gräfe, R Pries, ... International journal of nanomedicine 9, 5025, 2014 | 57 | 2014 |
| Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic–induced necroptosis B Uzunparmak, M Gao, A Lindemann, K Erikson, L Wang, E Lin, SJ Frank, ... JCI insight 5 (23), 2020 | 35 | 2020 |
| Replication stress leading to apoptosis within the S-phase contributes to synergism between vorinostat and AZD1775 in HNSCC harboring high-risk TP53 mutation N Tanaka, AA Patel, L Tang, NL Silver, A Lindemann, H Takahashi, ... Clinical Cancer Research 23 (21), 6541-6554, 2017 | 28 | 2017 |
| Combined inhibition of Rad51 and Wee1 enhances cell killing in HNSCC through induction of apoptosis associated with excessive DNA damage and replication stress A Lindemann, AA Patel, L Tang, N Tanaka, FO Gleber-Netto, MD Bartels, ... Molecular Cancer Therapeutics 20 (7), 1257-1269, 2021 | 16 | 2021 |
| Biological properties of superparamagnetic iron oxide nanoparticles A Lindemann, R Pries, K Lüdtke-Buzug, B Wollenberg IEEE Transactions on Magnetics 51 (2), 1-4, 2015 | 16 | 2015 |
| COTI-2, a potent orally available small molecule targeting mutant p53, with promising efficacy as monotherapy and combination treatment in preclinical tumor models. RT Ho, KY Salim, A Lindemann, AA Patel, H Takahashi, L Wang, M Zhao, ... Journal of Clinical Oncology 36 (15_suppl), 6040-6040, 2018 | 5 | 2018 |
| Loss of Caspase-8 function in combination with SMAC mimetic treatment sensitizes Head and Neck Squamous Carcinoma to radiation through induction of necroptosis B Uzunparmak, M Gao, A Lindemann, K Erikson, L Wang, E Lin, S Frank, ... bioRxiv, 2020 | 2 | 2020 |
| Nanoparticel labelling of stem cell populations in head and neck cancer. A Lindemann, K Lüdtke-Buzug, B Hüsing, R Pries, TM Buzug, ... Journal of Stem Cells & Regenerative Medicine 6 (2), 143-143, 2010 | 2 | 2010 |
| Targeting TP53 to augment therapeutic response in head and neck cancer AA Osman, A Lindemann, L Wang, SJ Frank, JN Myers Improving the Therapeutic Ratio in Head and Neck Cancer, 65-88, 2020 | 1 | 2020 |
| Abstract NG07: Cancer takes a nerve: Loss of p53 drives neuron reprogramming in head and neck cancer M Amit, H Takahashi, MP Dragomir, S Anfossi, A Lindemann, ... Cancer Research 81 (13 Supplement), NG07-NG07, 2021 | | 2021 |
| Abstract PR08: Inhibition of ATR as a therapeutic strategy to overcome cisplatin resistance in HNSCC A Lindemann, H Takahashi, AA Patel, WN Hittelman, AA Osman, ... Clinical Cancer Research 26 (12 Supplement 2), PR08-PR08, 2020 | | 2020 |
| Inhibition of ATR as a therapeutic strategy to overcome cisplatin resistance in HNSCC A Lindemann, H Takahashi, AA Patel, WN Hittelman, AA Osman, ... CLINICAL CANCER RESEARCH 26 (12), 28-29, 2020 | | 2020 |
| Caspase-8 is a novel candidate driver gene in head and neck squamous cell carcinoma B Uzunparmak, A Lindemann, MJ Frederick, JN Myers, CR Pickering Clinical Cancer Research 23 (23 Supplement), 04-04, 2017 | | 2017 |
| Synergistic antitumor activity of olaparib combined with AZD1775 in head and neck squamous cell carcinoma H Takahashi, A Lindemann, AA Patel, W Liu, N Tanaka, L Tang, M Zhao, ... Clinical Cancer Research 23 (23 Supplement), 44-44, 2017 | | 2017 |
| Plattenepithelkarzinome des Kopf-Hals Bereiches: Identifizierung und Charakterisierung von tumorassoziierten Signalprozessen A Lindemann Universität zu Lübeck, 2013 | | 2013 |
